Brian D Carter
Overview
Explore the profile of Brian D Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
4151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stevens V, Carter B, Jacobs E, McCullough M, Teras L, Wang Y
Breast Cancer Res
. 2023 Feb;
25(1):15.
PMID: 36726109
No abstract available.
2.
Stevens V, Carter B, Jacobs E, McCullough M, Teras L, Wang Y
Breast Cancer Res
. 2023 Jan;
25(1):5.
PMID: 36650550
Background: Breast cancer incidence rates have not declined despite an improvement in risk prediction and the identification of modifiable risk factors, suggesting the need to identify novel risk factors and...
3.
Pemov A, Wegman-Ostrosky T, Kim J, Koutros S, Douthitt B, Jones K, et al.
JCO Precis Oncol
. 2021 Dec;
5.
PMID: 34964002
Purpose: Previous studies have shown an approximately two-fold elevation in the relative risk of urinary bladder cancer (UBC) among people with a family history that could not be entirely explained...
4.
Townsend M, Trabert B, Fortner R, Arslan A, Buring J, Carter B, et al.
Int J Epidemiol
. 2021 Oct;
51(3):e73-e86.
PMID: 34652432
No abstract available.
5.
Westmaas J, Strollo S, Newton C, Carter B, Diver W, Flanders W, et al.
Cancer Epidemiol Biomarkers Prev
. 2021 Aug;
30(10):1956-1964.
PMID: 34348959
Background: Cannabis use is increasing, including among smokers, an at-risk population for cancer. Research is equivocal on whether using cannabis inhibits quitting cigarettes. The current longitudinal study investigated associations between...
6.
Boddicker N, Hu C, Weitzel J, Kraft P, Nathanson K, Goldgar D, et al.
J Clin Oncol
. 2021 Jul;
39(31):3430-3440.
PMID: 34292776
Purpose: The prevalence of germline pathogenic variants (PVs) in established breast cancer predisposition genes in women in the general population over age 65 years is not well-defined. However, testing guidelines...
7.
Coignard J, Lush M, Beesley J, OMara T, Dennis J, Tyrer J, et al.
Nat Commun
. 2021 May;
12(1):2986.
PMID: 33990587
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.
8.
Coignard J, Lush M, Beesley J, OMara T, Dennis J, Tyrer J, et al.
Nat Commun
. 2021 Feb;
12(1):1078.
PMID: 33597508
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers....
9.
Moore S, Mazzilli K, Sampson J, Matthews C, Carter B, Playdon M, et al.
Metabolites
. 2021 Feb;
11(2).
PMID: 33578791
Breast cancer is the most common cancer in women, but its incidence can only be partially explained through established risk factors. Our aim was to use metabolomics to identify novel...
10.
Conti D, Darst B, Moss L, Saunders E, Sheng X, Chou A, et al.
Nat Genet
. 2021 Jan;
53(3):413.
PMID: 33473200
No abstract available.